BFRI Biofrontera Inc.
$0.84▲ +2.17%
Healthcare
Other
Volume 94.3K
Avg Volume (10D) 188.2K
Key Metrics & Fundamentals
Market Cap
$12.47M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.56 - 1.66
% vs 50 MA
-29.26%
% vs 200 MA
-18.66%
RSI-14
36.2
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.56
Free Cash Flow
-$1.66M
Gross Rev
$12.00M
Gross Profit
$9.59M
EBITDA
-$302,000
COGS
$2.41M
Operating Exp
$10.12M
Operating Income
-$524,000
EBIT
-$524,000
Pretax Income
-$581,000
Net Income
-$604,000
EPS (Diluted)
-0.05
Price & Volume History
Loading chart…
Recent News
Biofrontera Submits Supplemental New Drug Application to FDA to Expand Ameluz® Red Light PDT to Actinic Keratoses on the Full Body
GlobeNewswire · Oct 8, 2026 9:22 AM ET
Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma
GlobeNewswire · Sep 14, 2026 9:26 AM ET
Biofrontera (BFRI) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 11:58 AM ET
Biofrontera Inc. Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 8:30 AM ET
Biofrontera Inc (BFRI) (Q2 2026) Earnings Call Highlights: Strong Ameluz Growth Drives Revenue ...
GuruFocus.com · Aug 13, 2026 7:03 PM ET
Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 13, 2026 10:10 AM ET
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth
GlobeNewswire · Aug 13, 2026 8:51 AM ET
Earnings To Watch: Biofrontera Inc (BFRI) Q2 2026 -- GF Value Sees 51% Downside
GuruFocus.com · Aug 12, 2026 9:35 AM ET
Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026
GlobeNewswire · Aug 5, 2026 4:15 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See BFRI's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.